JP MORGAN/PUT/BOSTON SCIENTIFIC/40/0.1/17.01.25 | Real-time Bid/Ask 13:27:33 2024-06-18 EDT | ||
| 0.055 EUR / 0.075 EUR | +25.00% |
|
| Current month | -5.45% | ||
| 1 month | -11.86% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-18 | 0.057 | +9.62% |
| 24-06-17 | 0.052 | -8.77% |
| 24-06-14 | 0.057 | +3.64% |
| 24-06-13 | 0.055 | +12.24% |
| 24-06-12 | 0.049 | +25.64% |
Delayed Quote Börse Stuttgart
Last update June 18, 2024 at 03:14 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JL03GQ |
| ISIN | DE000JL03GQ0 |
| Date issued | 2023-04-05 |
| Strike | 40 $ |
| Maturity | 2025-01-17 (213 Days) |
| Parity | 10 : 1 |
| Emission price | 0.23 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.44 € |
|---|---|
| Lowest since issue | 0.039 € |
| Spread | 0.02 € |
| Spread % | 27.03% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.19
USD
Average target price
82.26
USD
Spread / Average Target
+7.96%
- Stock Market
- Warrants
- Warrant
